6
68 J ournal of Natural Products, 2000, Vol. 63, No. 5
Notes
),
C-1), 134.9 (s), 133.8 (d), 133.6 (d), 130.4 (d), 51.4 (q), 33.9 (t),
0.2 (t), 30.0 (t), 28.8 (t), 28.6 (t), 24.7 (t), 23.0 (t); HRFABMS
m/z 499.1228 (calcd for C27 Br-H, 499.1225).
yield): 1H NMR (CDCl
3.59 (2H, t, J ) 6.5 Hz, H-1), 1.62 (2H, br s, H-9), 1.49 (2H, m,
3
, 300 MHz) δ 7.87-7.68 (15H, m, C
6
H
5
3
1
3
H
32PO
2
2 3
H-2), 1.23 (12H, m, CH ); C NMR (CDCl , 75 MHz) δ 135.0
(s), 133.6 (d), 130.5 (d), 130.4 (d), 62.6 (t, C-1), 32.5 (t), 30.2
(t), 28.9 (t), 28.8 (t), 28.7 (t), 25.4 (t), 22.6 (t), 22.5 (t).
Meth yl 9,13-Dim eth yl-8-tetr a d ecen oa te. To a flame-
dried 50-mL three-necked round-bottom flask, equipped with
a pressure-equalizing dropping funnel, a reflux condenser, and
under a nitrogen atmosphere, was added 4.5 mL of anhydrous
t-BuOH and 0.13 g (3.3 mmol) of potassium. After the
potassium t-butoxide precipitated, the excess alcohol was
removed with a double-ended syringe, and the phosphonium
salt (1.6 g, 3.3 mmol), dissolved in THF, was then slowly added.
After 10 min, 6-methyl-2-heptanone (0.09 g, 0.70 mmol) was
also added to the reaction mixture. The reaction was allowed
to stand overnight, and then it was quenched with a saturated
ammonium chloride solution (25 mL), extracted with ether
10,13-Dim eth yl-9-tetr a d ecen -1-ol. This compound was
prepared from (9-hydroxynonyl)triphenylphosphonium bro-
mide (17.0 g, 35 mmol) and 5-methyl-2-hexanone (3.9 g, 34
mmol), in THF, using potassium t-butoxide (7.8 g, 70 mmol)
as base, following the procedure described above for the
synthesis of the other isomer. The desired product [5.6 g, 69%
yield of a 1:1 mixture of (Z/E)-isomers] was obtained after
evaporation of the solvent in vacuo and purification using Si
gel column chromatography (hexane-ether, 8:2): IR (neat) ν
3500-3100 (OH), 2957, 2924, 2858, 1664 (CdC), 1463, 1384,
max
(
2 × 50 mL), and dried over Na
2
SO
4
. After evaporation of the
1367, 1116, 1057, 723 cm-1
; H NMR (CDCl , 300 MHz) δ 5.10
1
3
solvent in vacuo, the crude product was chromatographed on
Si gel, eluting with hexane-ether (8:2, v/v), and this afforded
the desired product [0.13 g, 73% yield of a mixture of 1.4:1
[1H, m, H-9, (E) and (Z)], 3.63 [2H, t, J ) 6.6 Hz, H-1, (E) and
(Z)], 2.00-1.95 [5H, m, H-8, H-11, OH (E) and (Z)], 1.66 [3H,
s, Me-10, (Z)], 1.57 [3H, s, Me-10, (E)], 1.57-1.49 [3H, m, H-2,
(
Z/E)-isomers]: IR (neat) νmax 2958 (dCH), 2930, 2857, 1737
H-13, (E) and (Z)], 1.29-1.19 [12H, m, CH , (E) and (Z)], 0.89-
2
(CdO), 1622, 1465, 1384, 1366, 1261, 1171, 1091, 1024, 876,
0.87 [6H, d, J ) 6.3 Hz, H-14, Me-13, (E) and (Z)]; 13C NMR
-
1 1
8
7
2
06, 725 cm ; H NMR (CDCl
.0 Hz, H-8, (E) and (Z)], 3.66 [3H, s, -OCH
.30 [2H, t, J ) 7.5 Hz, H-2, (E) and (Z)], 1.99-1.90 [4H, m,
3
, 300 MHz) δ 5.09 [1H, t, J )
(CDCl , 75 MHz) δ 135.7 [s, C-10, (E)], 135.4 [s, C-10, (Z)],
3
3
, (E) and (Z)],
124.9 [d, C-9, (E)], 124.3 [d, C-9, (Z)], 63.1 [t, C-1, (E) and (Z)],
37.6 [t, C-11, (E)], 37.4 [t, C-12, (Z)], 37.3 [t, C-12, (E)], 32.8
[t, C-2, (E) and (Z)], 30.1 [t, (E) and (Z)], 29.9 [t, (E) and (Z)],
29.7 [d, C-13, (E) and (Z)], 29.7 [t, C-11, (Z)], 29.5 [t, (E) and
(Z)], 29.4 [t, (E) and (Z)], 29.3 [t, (E) and (Z)], 28.1 [t, C-8, (E)],
27.9 [t, C-8, (Z)], 25.7 [t, (E) and (Z)], 23.5 [q, Me-10, (E) and
(Z)], 22.6 [q, C-14, Me-13, (E) and (Z)]; HREIMS m/z 240.2459
(calcd for C H32O, 240.2453).
H-7, H-10, (E) and (Z)], 1.66 [3H, s, Me-9, (Z)], 1.65 [3H, s,
H-3, H-13, (E) and (Z)], 1.57 [3H, s, Me-9, (E)], 1.36-1.25 [10H,
m, (E) and (Z)], 0.87 [6H, d, J ) 6.6 Hz, H-14, Me-13, (Z)],
0
7
.86 [6H, d, J ) 6.6 Hz, H-14, Me-13, (E)]; 13C NMR (CDCl
5 MHz) δ 174.4 [s, C-1, (E) and (Z)], 135.5 [s, C-9, (Z)], 135.5
,
3
[
-
s, C-9, (E)], 125.0 [d, C-8, (Z)], 124.3 [d, C-8, (E)], 51.4 [q,
OCH , (E) and (Z)], 39.9 [t, C-10, (E)], 38.9 [t, C-10, (Z)], 38.7
1
6
3
1
0,13-Dim eth yl-9(Z)-tetr a d ecen -1-ol:
t
R
) 12.56 min,
[t, C-12, (E)], 38.6 [t, C-12, (Z)], 34.0 [t, C-2, (E) and (Z)], 29.1
[t, (E) and (Z)], 29.0 [t, (E) and (Z)], 28.9 [t, (E) and (Z)], 27.9
[t, C-7, (Z)], 27.7 [t, C-7, (E)], 25.8 [t, (E) and (Z)], 25.7 [t, (E)
+
GC-MS (70 eV) m/z 240 [M ] (9), 185 (1), 156 (1), 123 (11),
1
8
12 (10), 110 (19), 109 (23), 97 (16), 96 (22), 95 (37), 83 (33),
2 (46), 81 (41), 79 (11), 71 (11), 70 (21), 69 (100), 68 (30), 67
and (Z)], 24.9 [t, (E) and (Z)], 23.7 [q, Me-9, (E)], 23.4 [q, Me-
9
(49), 57 (66), 56 (73), 55 (98).
, (Z)], 22.6 [q, C-14, Me-13, (E) and (Z)].
1
0,13-Dim eth yl-9(E)-tetr a d ecen -1-ol:
t
R
) 12.76 min,
Meth yl 9,13-d im eth yl-8(Z)-tetr a d ecen oa te: t
R
) 12.79
+
GC-MS (70 eV) m/z 240 [M ] (9), 185 (1), 151(4), 123 (11),
+
min, GC-MS (70 eV) m/z 268 [M ] (18), 237 (10), 183 (10),
1
1
8
(
12 (10), 110 (20), 109 (23), 97 (15), 96 (22), 95 (37), 83 (34),
2 (49), 81 (42), 79 (10), 71 (11), 70 (21), 69 (100), 68 (32), 67
66 (17), 151 (23), 143 (33), 133 (10), 126 (45), 125 (13), 124
(
(
12), 123 (16), 111 (39), 110 (18), 109 (22), 98 (12), 97 (23), 96
16), 95 (20), 87 (17), 83 (63), 81 (34), 79 (13), 74 (21), 70 (37),
51), 57 (68), 56 (79), 55 (99).
0,13-Dim eth yltetr a d eca n -1-ol. This product was ob-
tained in a 100% yield from the catalytic hydrogenation (PtO
1
6
9 (94), 67 (38), 57 (35), 55 (100).
2
)
Meth yl 9,13-d im eth yl-8(E)-tetr a d ecen oa te: t
R
) 12.99
+
of 10,13-dimethyl-9-tetradecen-1-ol (0.93 g, 3.88 mmol) using
the same procedure as described above for the other isomer:
IR (neat) νmax 3500-3100 (OH), 2960, 2934, 2857, 1464, 1383,
min, GC-MS (70 eV) m/z 268 [M ] (18), 237 (10), 166 (16),
1
51 (21), 143 (20), 126 (41), 125 (11), 124 (11), 123 (14), 111
(
(
35), 110 (17), 109 (20), 98 (11), 97 (21), 96 (15), 95 (19), 87
15), 83 (59), 81 (32), 79 (12), 74 (20), 70 (35), 69 (90), 67 (38),
-
1 1
1
377, 1366, 1116, 1059, 716 cm ; H NMR (CDCl
δ 3.62 (2H, t, J ) 6.6 Hz, H-1), 1.85 (1H, s, -OH), 1.57-1.47
3H, m, H-2, H-13), 1.29-1.07 (19H, m, CH ), 0.86 (3H, d, J )
.6 Hz, H-14), 0.85 (3H, d, J ) 6.6 Hz, Me-13), 0.82 (3H, d,
3
, 300 MHz)
5
7 (34), 55 (100).
Meth yl 9,13-Dim eth yltetr a d eca n oa te (1). Into a 25-mL
(
2
6
round-bottom flask was placed 0.019 g (0.07 mmol) of methyl
,13-dimethyl-8-tetradecenoate in 10 mL of distilled MeOH
together with catalytic amounts of PtO . After 24 h under a
1
3
J ) 6.4 Hz, Me-10); C NMR (CDCl
3
2
3
, 75 MHz) δ 63.0 (t, C-1),
7.0 (t), 36.3 (t), 34.7 (t), 33.0 (t), 32.7 (d), 30.0 (t), 29.6 (t),
9.4 (d), 28.3 (t), 27.1 (t), 25.7 (t), 22.8 (t), 22.6 (q), 19.7 (q);
GC-MS (70 eV) m/z 242 [M ] (0.02), 241 (0.09), 224 (0.2), 210
0.06), 196 (0.5), 181 (0.4), 168 (11), 153 (10), 140 (10), 125
9
2
hydrogen-filled balloon the reaction mixture was filtered and
the solvent evaporated in vacuo, affording the saturated
methyl ester 1 (0.019 g, 100% yield): H NMR (CDCl
MHz) δ 3.66 (3H, s, -OCH ), 2.30 (2H, t, J ) 7.6 Hz, H-2),
1
1
0
1
+
(
1
3
, 500
(
2
15), 112 (15), 97 (39), 83 (39), 69 (48), 57 (100); HREIMS m/z
3
+
24.2499 [M - H
2
O] (calcd for C16
H
32, 224.2504).
.61 (2H, m, H-3), 1.51 (1H, m, H-13), 1.35-1.21 (15H, m),
Meth yl 10,13-Dim eth yltetr a d eca n oa te (2). To a solution
of pyridinium dichromate (2.2 g, 5.9 mmol) dissolved in DMF
20 mL) was added 10,13-dimethyltetradecanol (0.26 g, 1.08
mmol) dissolved in DMF (5 mL). The mixture was allowed to
react for 20 h. The reaction mixture was then quenched with
.14-1.11 (2H, m, H-12), 0.86 (6H, d, J ) 6.6 Hz, Me-13, H-14),
.83 (3H, d, J ) 6.6 Hz, Me-9); 1 C NMR (CDCl
3
3
, 125 MHz) δ
(
3
74.4 (s, CdO), 51.5 (q, -OCH ), 39.3 (t), 37.3 (t), 37.0 (t), 34.1
(t), 32.7 (d, C-9), 29.3 (t), 29.2 (t), 28.1 (t), 28.0 (d, C-13), 27.0
(t), 24.9 (t), 24.8 (t), 22.7 (q, C-14), 22.6 (q, C-15), 19.7 (q, Me-
+
2 4
water, extracted with ether, and dried over Na SO . The
9
); GC-MS (70 eV) m/z 270 [M ] (8), 171 (13), 153 (6), 143
product thus obtained was immediately reacted with catalytic
amounts of HCl in refluxing MeOH (25 mL) for 24 h. After
this time the solvent was removed in vacuo, affording only
traces of the known saturated methyl ester 2 together with
residual aldehyde.5
(16), 135 (6), 115 (7), 111 (8), 101 (9), 97 (13), 86 (62), 83 (16),
7
5 (20), 74 (100), 71 (24), 69 (34), 67 (6), 57 (47), 55 (51).
N-9,13-Dim eth yltetr a d eca n oylp yr r olid in e: GC-MS (70
+
eV) m/z 309 [M] (2), 294 (1), 280 (0.1), 266 (1), 252 (0.3), 238
(
1
(
1), 224 (1), 210 (0.2), 196 (3), 182 (1), 168 (2), 154 (1), 140 (3),
26 (17), 114 (8), 113 (100), 98 (9), 85 (6), 71 (11), 70 (14), 57
8), 56 (7), 55 (19).
9-Hydr oxyn on yl)tr iph en ylph osph on iu m Br om ide. This
Ack n ow led gm en t. This work was supported by the Na-
tional Institutes of Health (NIH) under grant no. 5S06GM08102.
We thank Dr. Abimael D. Rodr ´ı guez (UPR-R ´ı o Piedras) for a
sample of C. podatypa. Mr. Ra u´ l Blanco performed the
HREIMS determinations at the Materials Characterization
Center (MCC).
(
compound was prepared from triphenylphosphine (13.9 g, 53
mmol) and 9-bromo-1-nonanol (11.8 g, 53 mmol), in benzene,
following the same procedure as detailed above for the other
1
1
salt. The salt was obtained as a clear syrup (18.1 g, 71%